Virtual Patients...Real Results

Entelos is a life sciences company improving human health through predictive biosimulation. Using in silico disease models and a virtual patient approach, Entelos identifies and validates targets, develops biomarkers, improves the success rates of clinical trials, and helps bring therapeutics to market faster.
News Releases  » Media Coverage  » Events  »
Option Grants - May 20
Result of AGM - May 20
Entelos Announces Agreement with Lilly - April 30
For information on Entelos toxicogenomics solutions including DrugMatrix® and ToxFX™, please visit the Iconix website.
Pfizer Enters into Research Consortium to Expand Understanding of Diabetes and Obesity Pathobiology - Pfizer Press Release, April 25, 2008
Over here and doing well - Investors Chronicle, January 29, 2008
Pharma Futurology - British Telecommunications, 2007
ADA 68th Scientific Sessions - San Francisco, California
June 6
Beyond Genome - Applying Systems Biology - San Francisco, California June 9 - 11
Beyond Genome - Personal Medicine - San Francisco, California
June 10 - 11

Visit Realab™, Entelos' online simulation tool.
Copyright© 2008 Entelos, Inc. All rights reserved Disclaimer (U.S. Visitors)